Translational Research: Screening
Screening for small molecule or non-viral biologics may involve a variety of approaches at differing scales. Some examples are high throughput screening of millions of small molecules in a cellular assay, testing a few hundred FDA-approved compounds in an ex vivo culture system, or panning through a phage-display library for neutralizing peptides.
Target AssayScreeningHits and
HitHit to LeadLead Series
NIH Funding Opportunities
PA-16-374, Assay Development and Screening to Discover Therapeutic or Imaging Agents for Diseases of Interest to the NIDDK (R01) has expired. The NIDDK is still interested in supporting this type of translational science and another potential option is to apply to the Parent R01 NOFO (PA-20-185) and consider requesting review assignment to any of CSR’s Drug Synthesis, Discovery, Disposition, and Xenobiotics study sections, or another relevant review panel. Applicants should consult the NIH/CSR study section descriptions before requesting a specific review panel.
Please reach out to one of the Staff Contacts listed below if you have any questions.
- Academic Drug Discovery Consortium
- Academic Screening Facilities
- NIH Molecular Libraries and Imaging
- NIDDK Small Business Programs
Division of Kidney, Urologic, and Hematologic Diseases
Dr. Anna Sadusky
Division of Digestive Diseases and Nutrition
Dr. Bonnie Burgess-Beusse
Division of Diabetes, Endocrinology, and Metabolic Diseases
Dr. Yan Li